CTRI Number |
CTRI/2020/03/024013 [Registered on: 17/03/2020] Trial Registered Prospectively |
Last Modified On: |
06/07/2023 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
A study comparing mixture of local anaesthetic agents lignocaine and ropivacaine versus sequential lignocaine followed by ropivacaine in patients undergoing surgery on hands and arms under regional anaesthesia. |
Scientific Title of Study
|
A randomized double blinded study comparing block characteristics of mixture of lignocaine and ropivacaine versus sequential lignocaine followed by ropivacaine in patients undergoing upper limb surgery under supra-clavicular brachial plexus nerve block. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Mridul Dhar |
Designation |
Assistant Professor, Anaesthesiology |
Affiliation |
AIIMS, Rishikesh |
Address |
Veerbhadra Road, Rishikesh
Dehradun UTTARANCHAL 249203 India |
Phone |
9717778374 |
Fax |
|
Email |
mriduldhar@hotmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Mridul Dhar |
Designation |
Assistant Professor, Anaesthesiology |
Affiliation |
AIIMS, Rishikesh |
Address |
Veerbhadra Road, Rishikesh
UTTARANCHAL 249203 India |
Phone |
9717778374 |
Fax |
|
Email |
mriduldhar@hotmail.com |
|
Details of Contact Person Public Query
|
Name |
Mridul Dhar |
Designation |
Assistant Professor, Anaesthesiology |
Affiliation |
AIIMS, Rishikesh |
Address |
Veerbhadra Road, Rishikesh
UTTARANCHAL 249203 India |
Phone |
9717778374 |
Fax |
|
Email |
mriduldhar@hotmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Mridul Dhar |
Address |
Department of Anaesthesiology, AIIMS, Rishikesh |
Type of Sponsor |
Other [Self] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Mridul Dhar |
AIIMS Rishikesh, Department of Anaesthesiology |
Veerbhadra Road, Rishikesh Dehradun UTTARANCHAL |
9717778374
mriduldhar@hotmail.com |
|
Details of Ethics Committee
Modification(s)
|
No of Ethics Committees= 2 |
Name of Committee |
Approval Status |
Institutional ethics committee, AIIMS Rishikesh |
Approved |
Institutional ethics committee, AIIMS Rishikesh |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: M959||Acquired deformity of musculoskeletal system, unspecified, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Lignocaine and Ropivacaine mixture |
Technique of Mixture of Lignocaine and Ropivacaine in USG guided supraclavicular brachial plexus block for upper limb surgery |
Intervention |
Sequential Lignocaine followed by Ropivacaine |
Sequential Lignocaine followed by Ropivacaine in USG guided supraclavicular brachial plexus block for upper limb surgery |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
Weighing more than 60 kg, planned for unilateral upper limb surgery |
|
ExclusionCriteria |
Details |
Patient refusal, coagulation or bleeding disorders, local site infection, any nerve injury/ neuropraxia/ paralysis, history of allergy or anaphylaxis to ropivacaine or lignocaine, pregnant females and block failure due to technical reasons. |
|
Method of Generating Random Sequence
|
Random Number Table |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Percentage of patients with complete sensory block in all 4- nerve areas (musculo-cutaneous, median, radial, ulnar) at 10 minutes post injection. |
Percentage of patients with complete sensory block in all 4- nerve areas (musculo-cutaneous, median, radial, ulnar) at 10 minutes post injection. |
|
Secondary Outcome
|
Outcome |
TimePoints |
Time to onset of first sensory block, time to onset of complete sensory block, time to complete motor block, duration of analgesia, procedure time, block failures, duration of sensory block, duration of motor block, and complication rates ( last three reading will be observed in post-anaesthesia care unit every one hour and in ward every 2 hours by in-charge nurse or resident. |
Time to onset of first sensory block, time to onset of complete sensory block, time to complete motor block, duration of analgesia, procedure time, block failures, duration of sensory block, duration of motor block, and complication rates ( last three reading will be observed in post-anaesthesia care unit every one hour and in ward every 2 hours by in-charge nurse or resident. |
|
Target Sample Size
|
Total Sample Size="66" Sample Size from India="66"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="68" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
17/03/2020 |
Date of Study Completion (India) |
Date Missing |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
Studies have been
conducted on use of ropivacaine, bupivacaine and lignocaine in various
combinations in various nerve blocks and neuraxial blocks. There is no clear
consensus on appropriate use of mixtures of these agents specially in brachial
plexus nerve blocks. Ropivacaine is an established safer, equally efficacious
alternative to bupivacaine. We intend to compare use of a short acting drug
lignocaine and long acting drug Ropivacaine as a mixture versus undiluted
sequential injections on block characteristics of ultrasound guided nerve block
for upper limb surgeries. |